169 related articles for article (PubMed ID: 24286573)
1. Methotrexate: new uses for an old drug.
Hashkes PJ; Becker ML; Cabral DA; Laxer RM; Paller AS; Rabinovich CE; Turner D; Zulian F
J Pediatr; 2014 Feb; 164(2):231-6. PubMed ID: 24286573
[No Abstract] [Full Text] [Related]
2. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
3. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
Ćalasan MB; Wulffraat NM
Expert Rev Clin Immunol; 2014 Jul; 10(7):843-54. PubMed ID: 24857620
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids in juvenile idiopathic arthritis.
Malattia C; Martini A
Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
Livermore P
Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
[TBL] [Abstract][Full Text] [Related]
7. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
8. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
van Dijkhuizen EH; Wulffraat NM
Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R
J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359
[TBL] [Abstract][Full Text] [Related]
10. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
Roszkiewicz J; Smolewska E
Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
[TBL] [Abstract][Full Text] [Related]
11. Development of pylomatrixoma after the subcutaneous injection of methotrexate for the treatment of juvenile idiopathic arthritis.
Afonso Pérez E; Garcia Porrua C; Castiñeiras Mato IM; Bal Nieves F
Reumatol Clin; 2012; 8(6):380-1. PubMed ID: 22858519
[No Abstract] [Full Text] [Related]
12. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.
Pastore S; Stocco G; Moressa V; Zandonà L; Favretto D; Malusà N; Decorti G; Lepore L; Ventura A
Rheumatol Int; 2015 Apr; 35(4):619-27. PubMed ID: 25240429
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan.
Mori M; Naruto T; Imagawa T; Murata T; Takei S; Tomiita M; Itoh Y; Fujikawa S; Yokota S
Mod Rheumatol; 2009; 19(1):1-11. PubMed ID: 18815725
[TBL] [Abstract][Full Text] [Related]
14. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.
Bulatovic M; Heijstek MW; Van Dijkhuizen EH; Wulffraat NM; Pluijm SM; de Jonge R
Ann Rheum Dis; 2012 Sep; 71(9):1484-9. PubMed ID: 22473625
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
Fox EJ; Leeder JS; Ye SQ; Becker ML
J Rheumatol; 2013 May; 40(5):741-2. PubMed ID: 23637381
[No Abstract] [Full Text] [Related]
16. Use of methotrexate in juvenile idiopathic arthritis.
Ramanan AV; Whitworth P; Baildam EM
Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
[TBL] [Abstract][Full Text] [Related]
17. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
18. The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
Becker ML; Gaedigk R; van Haandel L; Thomas B; Lasky A; Hoeltzel M; Dai H; Stobaugh J; Leeder JS
Arthritis Rheum; 2011 Jan; 63(1):276-85. PubMed ID: 20954192
[TBL] [Abstract][Full Text] [Related]
19. Juvenile idiopathic arthritis in the new world of biologics.
Ostring GT; Singh-Grewal D
J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis.
Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A
J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
